Stryker Corporation
SYK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -13.64 | 1.20 | 2.77 | -1.81 |
| FCF Yield | 0.96% | 0.61% | 0.09% | 1.21% |
| EV / EBITDA | 113.50 | 112.82 | 151.66 | 186.42 |
| Quality | ||||
| ROIC | 2.29% | 2.89% | 2.48% | 4.51% |
| Gross Margin | 63.60% | 62.27% | 62.73% | 61.98% |
| Cash Conversion Ratio | 1.79 | 1.26 | 0.38 | 3.54 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.03% | 6.98% | 7.00% | 6.99% |
| Free Cash Flow Growth | 45.80% | 630.71% | -92.37% | 27.68% |
| Safety | ||||
| Net Debt / EBITDA | 9.79 | 10.03 | 14.51 | 13.22 |
| Interest Coverage | 0.00 | 8.56 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.41 | 0.43 | 0.43 | 0.51 |
| Cash Conversion Cycle | 212.17 | 210.95 | 210.68 | 169.59 |